Table 1 Baseline characteristics
Group | ||
|---|---|---|
Control n = 73 | NMES n = 76 | |
Patient characteristics | ||
Age, years | 63.7 ± 18.2 | 62.8 ± 17.4 |
Female sex, n (%) | 42 (57.5%) | 38 (50.0%) |
BMI (kg/m2) | 25.2 ± 4.2 | 24.8 ± 3.3 |
Ethnicity, Caucasians, n (%) | 61 (83.6%) | 55 (72.4%) |
Clinical variables at ICU admission | ||
Braden score | 13.6 ± 3.6 | 14.3 ± 3.5 |
SAPS 3 | 34.0 [25.0–50.5] | 34.0 [25.7–53.7] |
SOFA | 2.0 [0.0–4.0] | 2.0 [0.0–4.0] |
Use of MV, n (%) | 17 (23.3%) | 14 (18.4%) |
RASS | − 2 [0 a –3] | − 2 [− 1 a − 5] |
IMS | 1.0 [0.0–1.0] | 1.0 [0.0–2.7] |
Diagnosis at ICU admission, n (%) | ||
Stroke | 20 (27.4%) | 28 (36.8%) |
Respiratory disease | 19 (26.0%) | 14 (18.4%) |
Cardiovascular disease | 15 (20.5%) | 13 (17.1%) |
Infection | 11 (15.1%) | 7 (9.2%) |
Gastrointestinal disease | 8 (11.0%) | 6 (7.9%) |
Chronic kidney disease | 5 (6.8%) | 8 (10.5%) |
Cancer | 3 (4.1%) | 7 (9.2%) |
Trauma and postoperative | 4 (5.5%) | 4 (5.3%) |
Metabolic disorders | 3 (4.1%) | 4 (5.3%) |